
OmegaXL: Backed by Research
What you should know about ingredient studies.
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Similasan Eye Relief products
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Settled
(Preliminarily approved)
https://www.homeopathiceyedropsettlement.com/home
What you should know about ingredient studies.
Will master resell rights actually give you the dream life?
Tanya Gazdik, Media Post
Underwear seller strips a number of marketing claims after a TINA.org inquiry.
TINA.org notifies electric vehicle maker for second time in three years.